drugset / Trial / NCT07149376

To Assess the Efficacy of a Toothpaste Containing 8% Arginine as Compared to Colgate Cavity Protection Toothpaste in the Reduction of Dentinal Hypersensitivity.

NCT07149376

Phase 3 Completed 84 enrolled Colgate Palmolive
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this clinical investigation is to assess the efficacy of a toothpaste containing 8% arginine (Colgate-Palmolive Company, New York, NY, USA) as compared to a commercially available non-desensitizing toothpaste (Colgate Cavity Protection Toothpaste, Colgate-Palmolive Company, New York, NY, USA) in the reduction of dentinal hypersensitivity over an eight (8) week period.

Timeline

Start
2025-08-18
Primary completion
2025-10-14
Completion
2025-10-14

Drugs

EvaluationDrugModalityDoseRoute
Comparator Colgate Cavity Protection Toothpaste Unknown

Indications